NCT06710847
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06710847
Title A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors (SYLVER)
Acronym SYLVER
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
GSK Investigational Site RECRUITING Denver Colorado 80218 United States Details
GSK Investigational Site RECRUITING Detroit Michigan 48201 United States Details
GSK Investigational Site RECRUITING New York New York 10016 United States Details
GSK Investigational Site RECRUITING Philadelphia Pennsylvania 19104 United States Details
GSK Investigational Site RECRUITING Philadelphia Pennsylvania 19107 United States Details
GSK Investigational Site RECRUITING Melbourne Victoria 3000 Australia Details
GSK Investigational Site RECRUITING Chiba 277-8577 Japan Details
GSK Investigational Site RECRUITING Shizuoka 411-8777 Japan Details
GSK Investigational Site RECRUITING Tokyo 104-0045 Japan Details
GSK Investigational Site RECRUITING Tokyo 135-8550 Japan Details
GSK Investigational Site RECRUITING Daegu 41404 South Korea Details
GSK Investigational Site RECRUITING Gyeonggi-do 10408 South Korea Details
GSK Investigational Site RECRUITING Seoul 03080 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field